Search clinical trials for: rotavirus

Total 230 results

GlaxoSmithKline

Completed

To Assess Immunogenicity, Reactogenicity & Safety of 2 Formulations of GSK's HRV Vaccine as 2-dose Vaccination (Infants)

Infections, Rotavirus

Panama
GlaxoSmithKline

Completed

To Assess Safety, Reactogenicity & Immunogenicity of 2 Doses of GSK's Oral Human Rotavirus Vaccine in Pre-Term Infants

Infections, Rotavirus

Spain, Poland, France, Portugal
GlaxoSmithKline

Completed

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 8 Weeks of Age

Infections, Rotavirus

Taiwan
GlaxoSmithKline

Completed

Immune Response Post Pry Vaccination of 2 Formulations of DTPw-HBV Vaccine Given With Rotavirus Vaccine to Infants

Hepatitis B

Russian Federation
GlaxoSmithKline

Completed

Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2010-2011

Infections, Rotavirus
Danone Asia Pacific Holdings Pte, Ltd.

Terminated

Biomarkers in Saliva and Stool

Healthy

Singapore
GlaxoSmithKline

Completed

Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2006-2007

Infections, Rotavirus
GlaxoSmithKline

Completed

A Study to Explore the Existence of Horizontal Transmission of the RIX4414 Vaccine Strain Between Twins Within a Family.

Infections, Rotavirus

Dominican Republic
GlaxoSmithKline

Completed

Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Indian Infants

Infections, Rotavirus

India
PATH

Completed

Phase I/II Descending Age Study of P2VP8 Subunit Parenteral Rotavirus Vaccine in Healthy Toddlers and Infants

Evaluation of a Rotavirus Vaccine

South Africa
GlaxoSmithKline

Completed

Impact of Rotavirus Vaccination on Hospital Pressures at a Large Paediatric Hospital in the UK: an Ecological Study

Gastroenteritis
Sanofi Pasteur, a Sanofi Company

Completed

Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination

Virus Diseases | Bacterial Infections | Neisseria Meningitidis

Finland
GlaxoSmithKline

Completed

Effectiveness of Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants in Panama

Infections, Rotavirus

Panama
International Vaccine Institute
Bill and Melinda Gates Foundation; University of Vermont; University of Virginia and other collaborators

Completed

Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in INDIA (PROVIDE)

Poliomyelitis | Tropical Enteropathy

India
MSD Wellcome Trust Hilleman Laboratories Pvt. Ltd.
Parexel

Completed

Safety, Reactogenicity and Immunogenicity of Heat-stable Rotavirus Vaccine (HSRV) in Adults and Infants (HSRV)

Rotavirus Gastroenteritis

Bangladesh
Academisch Medisch Centrum - Universiteit van Amsterdam...
Centers for Disease Control and Prevention; Wageningen University and Research

Completed

The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses (Rota-biome)

Tetanus | Rotavirus Infections | Reaction - Vaccine Nos | Intestinal Bacteria Flora Disturbance | Streptococcal Pneumonia

Netherlands
Bayer

Completed

Study Evaluating Betaferons Safety and Tolerability In Pediatric Patients With Multiple Sclerosis

Multiple Sclerosis

Germany, Austria, United Kingdom, Israel, Belgium, Finland
GlaxoSmithKline

Completed

A Retrospective Survey of the Burden of Rotavirus Gastroenteritis (RV GE) and Nosocomial RV GE in Japan

Rotavirus Gastroenteritis | Nosocomial Rotavirus Gastroenteritis
GlaxoSmithKline

Completed

Impact of Rotavirus Vaccination on Hospitalisations for Rotavirus Gastroenteritis in Children Aged <5 Years in Australia

Gastroenteritis | Rotavirus Gastroenteritis
GlaxoSmithKline

Completed

Assess the Immunogenicity & Safety of 2 Doses of Oral Live Attenuated Human Rota(HRV)Vaccine in Healthy Infants in India

Infections, Rotavirus

India
GlaxoSmithKline

Completed

Effectiveness of Human Rotavirus Vaccine, Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants

Rotavirus Severe Gastroenteritis

Singapore
GlaxoSmithKline

Completed

Study to Evaluate the Safety of Rotarix™ in Chinese Children

Infections, Rotavirus

China
GlaxoSmithKline

Completed

Study to Assess the Safety of GSK Biologicals' Liquid Human Rotavirus Vaccine in Healthy Infants

Infections, Rotavirus

China
GlaxoSmithKline

Completed

Study to Evaluate the Reactogenicity and Safety of Rotarix™ in Chinese Adults

Infections, Rotavirus

China
GlaxoSmithKline

Completed

Serological Response to Porcine Circovirus Type 1 (PCV-1) and PCV-1 DNA in Stools of Infants Following Administration of Rotarix™

Rotavirus Infection | Evidence of PCV-1 Replication and/or Immune Response to the PCV-1 in HRV Vaccinated Infants
University of Oxford

Completed

Rotavirus Vaccine in Premature Babies (RotaNeo)

Gastroenteritis

United Kingdom
Dennis Clements
Merck Sharp & Dohme LLC

Completed

An Alternate Dosing Schedule for Pentavalent Rotavirus Vaccine (RotaTeq)

Gastroenteritis | Diarrhea

United States
Merck Sharp & Dohme LLC

Completed

Safety,Tolerability and Immunogenicity of Vaccination With Rotateq in Healthy Infants in India (V260-021)

Gastroenteritis | Rotavirus
Merck Sharp & Dohme LLC

Completed

Developing World Study for RotaTeq™ (V260-015)(COMPLETED)

Vomiting | Diarrhea | Fever
Merck Sharp & Dohme LLC

Completed

ROTATEQ Reexamination Study (V260-037)

Gastroenteritis Rotavirus
Merck Sharp & Dohme LLC

Completed

Phase III Placebo-controlled Study of V260 (RotaTeq™) in Japanese Healthy Infants (V260-029)(COMPLETED)

Gastroenteritis | Rotavirus
BioRed LLC

Unknown

A Study of Acequias Contamination & Association of Infectious Diseases in Peru

Water-Related Diseases

Peru
GlaxoSmithKline

Completed

Prophylactic Antipyretic Treatment in Children Receiving Pneumococcal Conjugate and Standard Infant Vaccines

Infections, Rotavirus

Czech Republic
GlaxoSmithKline

Completed

To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines

Infections, Rotavirus

Finland, Germany, Spain, Italy, France, Czech Republic
Academisch Medisch Centrum - Universiteit van Amsterdam...
University of Padova; Centers for Disease Control and Prevention; Aga Khan University and other collaborators

Completed

The Influence of the Microbiome on Rotavirus Vaccine Immunogenic Response in Infants in Karachi, Pakistan

Rotavirus

Pakistan
GlaxoSmithKline

Completed

Epidemiological, Observational and Post Marketing Study of Rotarix™ in Children With Severe Gastroenteritis in Belgium

Infections, Rotavirus

Belgium
GlaxoSmithKline

Completed

A Study to Estimate the Occurrence of Rotavirus Gastroenteritis in Children < 5 Years of Age, in Bulgaria and Latvia

Infections, Rotavirus

Bulgaria, Latvia
GlaxoSmithKline

Completed

Assess the Immunogenicity of the Human Rotavirus (HRV) Vaccine After Reconstitution Without Buffering Agent; & Evaluate the Immunogenicity, Reactogenicity & Safety of the Vaccine After Storage for 7 d at 37°C Following 2 Doses in Healthy Infants

Rotavirus Gastroenteritis

Thailand
University of Tartu

Unknown

The Epidemiology and Etiology of Acute Gastroenteritis Among Estonian Children After Introduction of Rotavirus Vaccines (ERVS)

Rotavirus Infection

Estonia
GlaxoSmithKline

Completed

Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210)

Infections, Rotavirus

Singapore
GlaxoSmithKline

Completed

Vaccine Efficacy Against Rotavirus Diarrhea; Vaccine Given With Routine Childhood Vaccinations in Healthy African Infants

Infections, Rotavirus

South Africa, Malawi
GlaxoSmithKline

Completed

A Study to Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants

Infections, Rotavirus

Singapore
GlaxoSmithKline

Completed

Study of 2 Doses of HRV Vaccine Given Concomitantly or Separately With Routine Vaccinations in Healthy Infants in USA

Infections, Rotavirus

United States
GlaxoSmithKline

Completed

A Study in Infants to Test Two Preparations (Freeze-dried or Liquid) of the Rotavirus Vaccine (HRV Vaccine).

Infections, Rotavirus

Finland
GlaxoSmithKline

Completed

Study of 2 Doses of HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants

Infections, Rotavirus

Argentina, Brazil, Dominican Republic, Panama, Colombia, Honduras
GlaxoSmithKline

Completed

To Evaluate Immunogenicity, Reactogenicity & Safety of 2 Doses of GSK Bio HRV Liquid Vaccine Given to Infants (Vietnam)

Infections, Rotavirus

Vietnam
GlaxoSmithKline

Completed

Study of 2 Doses of Oral Live Attenuated Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis

Infections, Rotavirus

Korea, Republic of
Newtricious R&D BV
Sprim Advanced Life Sciences

Completed

Intervention Trial in Early Age-related Macular Degeneration (I-TEAM)

Age-related Macular Degeneration (AMD)

United States, Germany, Netherlands, United Kingdom
GlaxoSmithKline

Completed

A Study to Test 2 Doses of the HRV Vaccine Given With or Without OPV in Healthy Infants in Bangladesh

Infections, Rotavirus

Bangladesh
GlaxoSmithKline

Completed

Study of Immunogenicity & Safety of 2 Different Formulations of Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis

Infections, Rotavirus

Finland

3

Subscribe